Skip to content

Mechanism of beta-hydroxybutyrate-mediated NF-kB p65 deacetylation modification in the treatment of neuropathic pain after spinal cord injury by transabdominal functional magnetic stimulation

Mechanism of beta-hydroxybutyrate-mediated NF-kB p65 deacetylation modification in the treatment of neuropathic pain after spinal cord injury by transabdominal functional magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086302
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

Regular treatment group:Receive regular medication and rehabilitation, not transabdominal functional magnetic stimulation.
Transabdominal functional magnetic stimulation group:In addition to receiving conventional medication and rehabilitation therapy, they received transabdominal functional magnetic stimulation with a se
Abdominal mid-frequency electrical stimulation group:Using the intermediate frequency electrical stimulator (Beijing Tianchangfu Medical Equipment Manufacturing Co., Ltd, model T99-C), the intermediat
10Hz transabdominal functional magnetic stimulation group:In addition to receiving conventional medication and rehabilitation therapy, they received transabdominal functional magnetic stimulation with
30Hz transabdominal functional magnetic stimulation group:In addition to receiving conventional medication and rehabilitation therapy, they received transabdominal functional magnetic stimulation with
50Hz transabdominal functional magnetic stimulation group:In addition to receiving conventional medication and rehabilitation therapy, they received transabdominal functional ma

Sponsors

Jiangsu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Meets the ASIA Disability Classification of Spinal Cord Injuries Grade A criteria as established by the American Spinal Injury Association;?Traumatic thoracic spinal cord injury (TSCI);?Ages range from 18 to 80;?Informed and signed informed consent for this study.

Exclusion criteria

Exclusion criteria: ?The presence of metallic foreign bodies or other implanted electronic devices in the body within 20 cm in diameter of the site of electrical or magnetic stimulation;?Currently using or have used antibiotics or probiotic preparations within 1 month prior to enrolment;?Those who have a comprehension disorder that prevents them from cooperating in the completion of the test.

Design outcomes

Primary

MeasureTime frame
Gut microbiota testing;Serum metabolomics assay;

Secondary

MeasureTime frame
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI);Dystonia assessment;Manual Muscle Testing;Modified Bathel Index;Neurogenic bowel dysfunction score;Brief pain inventory;Visual Analogue Scale/Score;Self-Rating Anxiety Scale;Self-rating depression scale;Electromyographic;Proinflammatory cytokine assay;

Countries

China

Contacts

Public ContactYu Binbin

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

coldrain24@163.com+86 138 5179 8144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026